Kyle Piskel
Chief Financial Officer · 3 filings · Latest: Mar 11, 2026
Adaptive Biotechnologies Corp
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADPT | PISKEL KYLE | — | Mar 11, 2026 | Proposed Sale | $14.52 | 18,672 | $271.1K | — | |
ADPT | Kyle Piskel | Chief Financial Officer | Mar 11, 2026 | Sale | $13.17 | 18,672 | $245.9K | 259,840 | |
ADPT | Kyle Piskel | Chief Financial Officer | Feb 4, 2026 | Sale | $18.46 | 2,145 | $39.6K | 216,637 | |
ADPT | Kyle Piskel | Chief Financial Officer | Feb 4, 2026 | Option Exercise | $12.14 | 2,145 | $26.0K | 218,782 | |
ADPT | KYLE PISKEL | — | Jan 12, 2026 | Proposed Sale | $15.76 | 11,081 | $174.6K | — | |
ADPT | KYLE PISKEL | — | Nov 28, 2025 | Proposed Sale | $19.72 | 162,820 | $3.2M | — |